Howard S Cheskin

Title: The Innovations of Howard S. Cheskin

Introduction

Howard S. Cheskin is a notable inventor based in Glencoe, Illinois. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release formulations. With a total of seven patents to his name, Cheskin's work has had a profound impact on medication administration and patient care.

Latest Patents

One of Cheskin's latest patents is a controlled release formulation of divalproex sodium. This innovative oral polymeric formulation is designed for once-a-day administration of valproate compounds, such as divalproex sodium. It exhibits significant advantages over previous sustained release formulations, minimizing the variation between peak and trough plasma levels of valproate over a 24-hour dosing period. The formulation follows a zero-order release pattern, resulting in essentially flat plasma levels of valproate once steady-state levels are achieved. This advancement leads to a significantly lower incidence of side effects for patients consuming such a formulation.

Career Highlights

Cheskin's career is marked by his dedication to improving pharmaceutical formulations. His work at Abbott Laboratories Corporation has allowed him to collaborate with other experts in the field and contribute to groundbreaking innovations. His patents reflect a commitment to enhancing patient outcomes through better medication delivery systems.

Collaborations

Cheskin has worked alongside talented colleagues, including Yihong Qiu and J. Daniel Bollinger. These collaborations have fostered an environment of innovation and have led to the development of effective pharmaceutical solutions.

Conclusion

Howard S. Cheskin's contributions to the field of pharmaceuticals through his innovative patents have significantly improved medication administration. His work continues to influence the industry and enhance patient care.